You are here: Industry Insights > clinical

News List

Marken Expands Services for Home-based Clinical Trials contractpharma
August 21, 2019
Direct to patient logistics include clinical drug storage, direct-to-patient delivery, biologic sample collection, central pharmacy and nursing services.
Provention Bio Appoints Clinical Development SVP contractpharma
August 21, 2019
Dr. Kell will lead the PRV-031 program, including the oversight of the Phase III PROTECT study and support of regulatory submissions.
Frontage Clinical Expands NJ Facilities contractpharma
August 15, 2019
Frontage Clinical Services, an associate of Frontage Laboratories, has completed renovations to Frontage Clinical’s center in Secaucus, NJ, to now accommodate clinical studies on tobacco and nicotine-containing products.
Advanced Clinical Opens New Office in Italy contractpharma
August 14, 2019
Company now able to serve clients in all major markets throughout Western Europe.
Ebola clinical trial stopped early due to positive results europeanpharmaceuticalreview
August 14, 2019
An Ebola clinical trial has been stopped early as Regeneron’s REGN-EB3 therapy shows superiority to ZMapp in preventing Ebola deaths.
Caladrius, Cognate Ink Clinical Manufacturing Agreement contractpharma
August 13, 2019
For phase 3 trial of CLBS14 in no-option refractory disabling angina.
Clinical trial reporting is improved by professional medical writers europeanpharmaceuticalreview
August 13, 2019
A new systematic review has shown that the speed and quality of clinical trial reports are improved by professional medical writers.
Researchers 'Spin' Clinical Trial Findings in Top Psych Journals drugs
August 07, 2019
Summary results of clinical trials published in top journals are often exaggerated, a new review charges.The review says such spin -- exaggerating the clinical significance of a treatment without...
FDA Grants Breakthrough Therapy Designation for Bempegaldesleukin, Opdivo Combination americanpharmaceuticalreview
August 02, 2019
Nektar Therapeutics and Bristol-Myers Squibb announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for investigational agent bempegaldesleukin (NKTR-214) in combination with ...
Eurofins Amatsigroup Rebrands to Eurofins CDMO contractpharma
August 01, 2019
Provides integrated, end-to-end solutions for pre-clinical and clinical outsourcing services.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page